82% buyers of institutions opening or closing positions this quarter
14 more new buyers than exits, ownership rose 0.00 percentage points vs the prior quarter, and 1 well-known fund manager in the top 25.
82% buyers of institutions opening or closing positions this quarter
200.0% institutional ownership
Ally Bridge Group portfolio allocation
Institutional ownership vs Biotechnology peers
No Form 4 insider transactions on file
Latest positioning in NERV across 13F flow, ownership shift, marquee holders, and holder-count growth.
Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in NERV held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FEDERATED HERMES, INC. | 5.1M | $30.8M | -4.8% | 73.120% | 0.05% |
| 2 | Vivo Capital, LLC | 4.3M | $26.0M | 0.0% | 61.816% | 2.17% |
| 3 | JANUS HENDERSON GROUP PLC | 4.3M | $25.9M | +47614.0% | 61.408% | 0.01% |
| 4 | BALYASNY ASSET MANAGEMENT LLC | 4.3M | $25.7M | β | 60.898% | 0.03% |
| 5 | Logos Global Management LP | 3.2M | $19.4M | -2.9% | 45.975% | 0.97% |
| 6 | FARALLON CAPITAL MANAGEMENT LLC | 2.4M | $14.2M | 0.0% | 33.820% | 0.08% |
| 7 | Foresite Capital Management VI LLC | 2.0M | $12.0M | β | 28.408% | 2.60% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $11.1M | β | 26.395% | 0.00% |
| 9 | Spruce Street Capital LP | 1.7M | $10.0M | 0.0% | 23.674% | 2.40% |
| 10 | Ally Bridge Group (NY) LLC | 1.7M | $10.0M | 0.0% | 23.674% | 8.06% |
| 11 | Trails Edge Capital Partners, LP | 1.4M | $8.5M | β | 20.292% | 1.96% |
| 12 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.4M | $8.5M | -50.0% | 20.292% | 0.01% |
| 13 | DV Trading LLC | 889K | $5.4M | β | 12.716% | 0.13% |
| 14 | ACUTA CAPITAL PARTNERS, LLC | 710K | $4.3M | 0.0% | 10.146% | 3.02% |
| 15 | MILLENNIUM MANAGEMENT LLC | 708K | $4.3M | +413.6% | 10.129% | 0.00% |
| 16 | BlackRock, Inc. | 625K | $3.8M | +759.9% | 8.936% | 0.00% |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 339K | $2.0M | +384.5% | 4.844% | 0.00% |
| 18 | VANGUARD FIDUCIARY TRUST CO | 264K | $1.6M | β | 3.776% | 0.00% |
| 19 | Seven Fleet Capital Management LP | 248K | $1.5M | β | 3.553% | 0.48% |
| 20 | MARSHALL WACE, LLP | 219K | $1.3M | β | 3.128% | 0.00% |
| 21 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 119K | $718K | β | 1.704% | 0.00% |
| 22 | NORTHERN TRUST CORP | 93K | $562K | β | 1.334% | 0.00% |
| 23 | RENAISSANCE TECHNOLOGIES LLC | 90K | $540K | -39.9% | 1.283% | 0.00% |
| 24 | UBS Group AG | 68K | $407K | +3639.4% | 0.966% | 0.00% |
| 25 | STATE STREET CORP | 56K | $340K | +134.6% | 0.806% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in NERV β a direct measure of their conviction.
Filings activity in NERV during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 44 | +47% | 199.99% | +0.00 pp | $231M | +114% |
| Q4 2025 | 30 | +30% | 199.99% | +188.56 pp | $108M | +2481% |
| Q3 2025 | 23 | +9.5% | 11.43% | +2.35 pp | $4M | +26% |
| Q2 2025 | 21 | +0.0% | 9.08% | 1.08 pp | $3M | +1.0% |
| Q1 2025 | 21 | 8.7% | 10.16% | 2.42 pp | $3M | 29% |
| Q4 2024 | 23 | +4.5% | 12.58% | 2.78 pp | $5M | 18% |
| Q3 2024 | 22 | +4.8% | 15.36% | 2.72 pp | $6M | 15% |
| Q2 2024 | 21 | β | 18.08% | β | $7M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
No recent Form 4 insider transactions on file for NERV.
Quick answers to the most common questions about buying NERV stock.
Based on Q1 2026 13F filings, institutional ownership of Minerva Neurosciences, Inc. stands at 200.0%, held across 44 reporting institutions.
FEDERATED HERMES, INC. is the largest reported institutional holder of NERV, with approximately 5,113,224 shares worth $0.03B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of NERV, including RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for NERV is 59 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
18 institutions opened new positions in NERV during Q1 2026, while 4 fully exited. 22 added to existing positions and 4 trimmed.
NERV institutional ownership rose by 0.00 percentage points quarter-over-quarter, with a net change of +14 holders.
The top 10 institutions account for 80.2% of all reported 13F value in NERV, and the top 25 account for 99.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.